UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:March 06, 2023
Accession Number:0001213900-23-015836
Submission Type:POS AM
CIK:0001817944
Company Name:Clarus Therapeutics Holdings, Inc.
File Number:333-259915
Clarus Therapeutics (NASDAQ:CRXT)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Clarus Therapeutics Charts.
Clarus Therapeutics (NASDAQ:CRXT)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Clarus Therapeutics Charts.